A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4
Clinical trial NCT01057667 · COMPLETED
Trial details
- NCT number
- NCT01057667
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-04-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.